Feds Take New Aim at Prescription Drug Prices: What to Expect from the Biden Administration & Congress
Instructor:
Dennis Weissman
Product ID: 706759
- Duration: 60 Min
Why Should You Attend:
Having inherited a handful of drug cost-cutting final rules proposed by the Trump White House, the Biden Administration has put forward a series of its own drug pricing initiatives even as Congress is poised to act on legislation containing key drug cost- cutting policies relating to Medicare & drug prices more generally.
Areas Covered in the Webinar:
- Background on prescription drug pricing issue
- Biden Administration reaction to Trump era drug pricing rules
- Impact of Biden White House executive order for reducing prescription drug prices
- Analysis of Biden call for Congress to cut drug costs including having Medicare negotiate drug prices
- Overview of HHS Drug Pricing Plan
- Review of key state actions impacting drug prices
- Senate finance committee principles for lowering drug prices & pending drug pricing bills in Congress
- Legislative status of infrastructure and budget reconciliation bills having drug pricing provisions.
- Pharma reacts to federal initiatives on drug pricing.
- Analysis of dynamics shaping federal actions on drug pricing in 2021 plus outlook for year ahead
Who Will Benefit:
Executives of pharmaceutical manufactures, drug distributors, benefit managers, health insurers/ payers, provider organizations, law firms, and consulting groups who have an interest in federal policy affecting prescription drug pricing in the U.S.
- C-level executives including CEOs
- President, Chief Operating Officer (COO)
- Chief Financial Officer (CFO)
- Chief Medical Officer (CMO), (CFO)
- Chief Technology Officer (CTO)
- Chief Data Officer (CDO)
- Chief Compliance Officer (CCO)
- Chief Knowledge Officer (CKO)
- Chief Marketing Officer (CMO)
- Vice President/ Director/senior
Dennis Weissman
President, Dennis Weissman and Associates LLC
Dennis Weissman is a nationally known, independent analyst, consultant, speaker and thought leader for the clinical laboratory and anatomic pathology sectors for the past three decades. He is President of Dennis Weissman & Associates, LLC, Falls Church, VA, a consultancy which provides market intelligence, business leadership, public policy insights and M&A advisory series to diagnostic and life science companies. Mr. Weissman has expertise is Medicare and healthcare reform policies and trends, laboratory and pathology payment and compliance issues as well as business and financial trends affecting the diagnostic other key health care sectors. He regularly speaks on a wide variety of healthcare topics during webinars, seminars and conferences sponsored by professional associations, medical groups and healthcare companies.
More Training By Experts
- How Medicare's Market-Based Payment System Is Upending the U.S. Clinical Laboratory Market
- Where FDA Is Heading in Regulating Laboratory-Developed Tests
- The Latest in CLIA Compliance for Clinical Labs
- Health Reform Turbulence in the Trump Era: Market Impact and 2018 Outlook
- How Medicare's Market-Based Payment System for Laboratory Services Will Change the Industry's Competitive Dynamics In 2019
Refund Policy
Our refund policy is governed by individual products and services refund policy mentioned against each of offerings. However in absence of specific refund policy of an offering below refund policy will be effective.
Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange. Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time. On-Demand Recording purchases will not be refunded as it is available for immediate streaming. However if you are not able to view the webinar or you have any concern about the content of the webinar please contact us at below email or by call mentioning your feedback for resolution of the matter. We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email [email protected] call +1-888-717-2436 (Toll Free).
